CPC Subgroup
C07D 455/06 containing benzo [a] quinolizine ring systems
Full Title
Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine > containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine > containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine > containing benzo [a] quinolizine ring systems
1 direct subcode
Child Classifications
Navigate with arrow keys, Enter to open
- C07D 455/08 having an isoquinolyl-1, a substituted isoquinolyl-1 or an alkylenedioxyisoquinolyl-1 radical linked through only one carbon atom, attached in position 2, e.g. emetine
Top Applicants
Top 10 applicants by patent filingsfor class C07, 2013–2023, worldwide · Source: EPO PATSTAT
- ROCHE CH 12,683
- NOVARTIS CH 10,775
- CHINESE ACADEMY OF SCIENCES 10,619
- BASF (BADISCHE ANILIN & SODA FABRIK) DE 9,511
- REGENERON PHARMACEUTICALS US 8,426
- BRISTOL-MYERS SQUIBB COMPANY US 7,979
- LG CHEM KR 7,978
- HARVARD UNIVERSITY US 7,706
- UNIVERSITY OF CALIFORNIA US 7,455
- SINOPEC (CHINA PETROCHEMICAL CORPORATION) 7,219